That's Sir Andrew Witty to you

All that talk about re-investing in Britain has paid off. GlaxoSmithKline ($GSK) CEO Andrew Witty (photo) was honored with a knighthood over New Year's after he promised increased spending on domestic facilities, staff and development. GSK's discounted pricing in poor countries must have helped, too. Report

Suggested Articles

Six months after WHO declared a pandemic, the list of drugs proven to work against the virus remains short. Now, Fujifilm has added its drug Avigan.

Humanigen has tapped Thermo Fisher to help scale production of monoclonal antibody lenzilumab for a possible emergency approval to treat COVID-19.

Rather than accept a filing based on phase 1/2 data, the FDA wants Novartis to run a phase 3 for a market-expanding version of gene therapy Zolgensma.